Abstract
The acetylation of α-tubulin on lysine 40 is a well-studied post-translational modification which has been associated with the presence of long-lived stable microtubules that are more resistant to mechanical breakdown. The discovery of α-tubulin acetyltransferase 1 (ATAT1), the enzyme responsible for lysine 40 acetylation on α-tubulin in a wide range of species, including protists, nematodes, and mammals, dates to about a decade ago. However, the role of ATAT1 in different cellular activities and molecular pathways has been only recently disclosed. This review comprehensively summarizes the most recent knowledge on ATAT1 structure and substrate binding and analyses the involvement of ATAT1 in a variety of cellular processes such as cell motility, mitosis, cytoskeletal organization, and intracellular trafficking. Finally, the review highlights ATAT1 emerging roles in human diseases and discusses ATAT1 potential enzymatic and non-enzymatic roles and the current efforts in developing ATAT1 inhibitors.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Microtubules (MTs), key components of the cytoskeletal architecture in eukaryotic cells, are formed by the polymerisation of α-tubulin and β-tubulin heterodimers in a polar fashion. Most cytoplasmic MTs are composed of 13 protofilaments. However, other protofilament arrangements are also found as in the 9 + 2 protofilament MTs of ciliary axonemes [1, 2]. MT properties and functions are finely regulated by the presence in different MTs of diverse tubulin isotypes and the occurrence of a variety of post-translational modifications (PTMs), giving rise to the so called “tubulin code” [3, 4].
PTMs occur on amino acids of both tubulin globular domain and C-terminal tail. α- and β-tubulin polyamination and phosphorylation, K252 β-tubulin acetylation and K394 α-tubulin acetylation are detected in the globular part of the protein, with K394 α-tubulin acetylation protruding on the MT surface at the dimer interface. Tyrosination/detyrosination, polyglycylation and polyglutamylation occur on the C-terminal tail of α- and β-tubulin (Fig. 1a) [3, 4]. Proteomic studies have identified 14 acetylation sites in α-tubulin and 12 acetylated residues in β-tubulin [5,6,7,8]. Among them, K40, K60 and K370 on α-tubulin and K58 on β-tubulin are luminal residues [8], but only K40 acetylation of α-tubulin has been extensively investigated [9]. Beside K40, K394 on α-tubulin and K252 on β-tubulin are two residues that have been consistently identified acetylated in proteomic studies on various organisms [5,6,7, 10, 11]. Recently, K394 acetylated α-tubulin has been characterized in the D. melanogaster nervous system, where it regulates axonal MT stability during synaptic morphogenesis [12]. K252 acetylation on β-tubulin is catalysed by the San acetyltransferase on soluble tubulin heterodimers. By using acetylation-mimicking β-tubulin mutants in human cultured cells, K252 acetylation has been shown to promote a conformational change that hampers dimer incorporation into MTs and slows down MT polymerisation [6].
To date, acetyl-K40 is the main residue on α-tubulin that has been associated with the presence of long-lived stable MTs [13,14,15]. Studies with purified acetylated and deacetylated MTs and live cell imaging of MTs have shown that K40 acetylation enhances the flexibility of MTs, giving them more resistance to mechanical breakdown and disassembly [13, 15]. Moreover, this covalent modification has also been linked to the recruitment of specific motor proteins on MTs, affecting intracellular trafficking [16, 17]. Notably, despite the relevance of K40 acetylation in MT functions, studies with non-acetylatable or acetyl-mimicking α-tubulin mutants in various organisms have shown that K40 acetylation is not essential for survival and its absence produces only mild phenotypes [18,19,20,21,22,23].
In this review, we will focus our attention on the α-tubulin acetyltransferase 1 (ATAT1). Its K40-specific acetylation of α-tubulin renders this enzyme a pivotal player in multiple MT-dependent cell functions. Although several detailed reviews have addressed the role of tubulin PTMs in cellular activities and molecular pathways [24,25,26], there is a substantial lack of information on ATAT1 with several unanswered questions on its activity. At present, it is still to be clarified whether ATAT1 performs its functions exclusively through the acetylation of α-tubulin or it also acts on different substrates [27]. Moreover, the non-enzymatic activity of ATAT1 remains still undefined [22, 28,29,30,31]. This review comprehensively summarizes the most recent knowledge on ATAT1 structure and functions, discusses the evidence supporting the involvement of ATAT1 in various physiological and pathological conditions, and highlights its potential in targeted therapy.
ATAT1 structure and interaction with microtubules
In 2010, human ATAT1 was discovered as the homologue of C. elegans MEC17 [22, 32], a lysine acetyltransferase related to the GCN5-related N-acetyltransferase (GNAT) superfamily [33]. The ATAT1 gene (also called αK40 TAT, αTAT, MEC-17 or C6orf134) is located on chromosome 6 of the human genome (6p21.33) and consists of 13 exons. Unlike C. elegans, no ATAT1 functional paralogues have been described in humans. Beside 421 amino acids and 46 kDa canonical ATAT1, 6 transcript variants, due to alternative splicing, have been identified (https://www.ncbi.nlm.nih.gov/gene/79969, Fig. 2a). The protein is composed of a N-terminal catalytic domain, which exhibits homology to other acetyltransferases and a C-terminal domain, which was not resolved in crystal structures [34]. The C-terminus has been predicted to be intrinsically disordered and to contain a nuclear export signal (NES) and a nuclear localization signal (NLS) [35] (Fig. 2b).
ATAT1 mediates the acetylation of K40 on α-tubulin [32]. Moreover, studies with wild-type or non-acetylatable K40 α-tubulin purified from Tetrahymena strains have shown that ATAT1 is unable to acetylate other lysine residues on α-tubulin and no recognisable activity has been observed towards purified histones [22]. This substrate specificity is likely to be related to an extensive interaction with α-tubulin that goes beyond the typical enzyme-substrate interaction [36]. To date, the only reported ATAT1 substrate different from α-tubulin is cortactin, an actin-binding protein involved in cell migration and invasion [27].
Several groups have solved the crystal structure of human ATAT1 catalytic domain bound to Ac-CoA (residues 1 to 196) [34, 36,37,38]. Compared to other lysine acetyltransferases, ATAT1 has a well-conserved co-substrate binding pocket, a distinct active site, and a putative α-tubulin binding site. The identified catalytic domain is composed of a central β-sheet with six antiparallel filaments flanked by three α-helices on each side. The central β-sheet also contains a structural motif called ‘hairpin β’ inserted between β3 and β6, which contacts a loop at the C-terminal end of the catalytic domain. The enzyme activity depends upon three conserved phenylalanine residues packed into a hydrophobic pocket within α2 helix. Moreover, 35 amino-terminal residues form a mostly random coiled-coil structure, which maintains Ac-CoA bound to α2 helix in the correct position. Ac-CoA is localised within a deep groove in the centre of the catalytic core and makes contacts with the enzyme via the α2, α4, and α6 helices, the β6 and β7 sheets, and the linker loops, so that ATAT1 makes more than 20 interactions of both hydrophobic and hydrophilic nature with Ac-CoA. The adenine base of Ac-CoA is inserted between K162 and R132 side chains (Fig. 2c). Thus, these two evolutionarily conserved amino acid residues are likely critical for Ac-CoA recognition [36, 37]. Moreover, R132 and S160 participate in stable interactions with CoA and Ac-CoA and are important for ATAT1 protein stability [39].
The application of acetylation assays helped to identify several residues essential in substrate binding and catalysis. D157 and C120 are both required for the catalytic activity of ATAT1. D157 is essential in the organisation of the active site because it aids to form the binding pocket for α-tubulin via a salt bridge. Mutations of this residue lead to enormous structural changes that cause ATAT1 inactivation [34]. ATAT1 is highly specific for the luminal K40 residue of α-tubulin, and R158, I64, R69, H75 and K102 residues on ATAT1 are involved in substrate binding. Indeed, R158 and I64 make the α-tubulin binding pocket hydrophobic and are required to bind and position K40 for acetylation, while R69, H75, and K102 supply the negative charge within the tubulin-binding groove and are required for the binding of the K40-containing α-tubulin loop: mutation of each single residue results in reduced levels of MT acetylation and aberrant substrate binding [37, 38]. The ATAT1 catalytic preference for MTs over free tubulin [32] indicates that the enzyme needs to enter the MT lumen for acetylating α-tubulin. By performing biochemical, fluorescence and electron microscopy experiments on purified ATAT1 and MTs it has been demonstrated that ATAT1 is able to enter the lumen of the tubular structures through the MT ends or through openings within the MT wall (Fig. 1b). Once inside the lumen, the enzyme does not move efficiently inside the MT, being the movement dependent on ATAT1 affinity for its α-tubulin binding sites [40, 41].
Thus, MT structure and ATAT1 affinity for binding sites are important determinants in the acetylation process. To date, it is still unclear whether co-factors/regulators may aid ATAT1 entry and mobility inside MTs, or ATAT1 itself may modulate MT dynamics to promote its access into the lumen.
Genetic studies of ATAT1 functions in different organisms
A plethora of studies on in vitro cultured cells and in vivo genetic models have identified the role of K40 α-tubulin acetylation in several cellular and developmental processes [9, 26]. Despite this, the contribution of ATAT1 in these processes remains undefined. An overview of the findings obtained in genetic studies on ATAT1 using different model organisms is presented in Table 1.
In the initial studies, deletion of MEC17 in T. thermophila and C. elegans, TAT in D. melanogaster or ATAT1 in mice did not markedly affect organism development or growth [18, 22, 23, 42]. This suggests that both ATAT1 and K40 acetylation are not essential for survival, as suggested by mutation studies of K40 α-tubulin in various organisms [18,19,20,21,22,23]. Conversely, acetylation-dependent MT functions might also be maintained through redundant or compensating mechanisms.
In C. elegans, MEC17 is only expressed in the six mechanosensory neurons, where the protein is required for maintaining a 15-protofilament MT structure typical of mechanosensory neurons in this species [31, 43, 44]. Studies on MEC17 mutants demonstrated impaired touch sensitivity, defective axonal transport and axon degeneration [22, 32, 45]. On the other hand, studies from animals overexpressing MEC17 in the mechanosensory neurons showed a loss of synaptic branches in MT neurons [29]. Furthermore, C. elegans strains expressing MEC17 catalytic mutants were shown to have similar frequencies of intact synaptic branches in wild-type and mutant animals, indicating that correct levels of MEC17 maintain synaptic branch stability independently from its acetyltransferase activity [29]. These results corroborate the suggestion for a structural role of the protein in MT stability put forward by several studies using MEC17/ATAT1 catalytic mutants in different organisms [28,29,30,31, 45].
In D. melanogaster, the MEC17 homologue (CG3967, named TAT) was identified as required for larval mechanosensation [18]. Loss-of-function mutants were viable, with no obvious morphological defects but displayed uncoordinated movements, as well as reduced male fertility and sperm motility [46]. During fly development, TAT regulates the larvae locomotion and the growth of synaptic boutons at the neuromuscular junction [30, 47].
D. rerio has a single MEC17 homologue, renamed ATAT1. In zebrafish, ATAT1 depletion caused loss of K40 acetylated tubulin and developmental defects such as reduced neck and head size, curved body shape and neuromuscular deficiencies. Notably, ATAT1-knockdown embryos showed a dramatic loss of K40 acetyl tubulin in neurons, but not in cilia, although no ATAT1 paralogues are known in zebrafish [32].
In mammals, ATAT1 functions during development have been studied in mouse knockout models homozygous for ATAT1. Consistent with findings in other organisms, ATAT1 -/- mice were viable and developed normally [23, 42], although decreased sperm motility and male fertility were observed [42]. Interestingly, ATAT1 is highly expressed in differentiating spermatids and in the flagella of elongating spermatids in mice [48], leading to the hypothesis that α-tubulin acetylation in spermatids is relevant for the formation of a normal spermatozoa tail and that α-tubulin acetylation disfunction may be involved in male infertility [48].
Defects in brain development connected to altered neuronal migration were observed in mutant mice and rats [23, 49, 50]. Notably, ATAT1 inactivation led to motor coordination deficits also in knockout adult mice, probably related to a striatal defect [49], and predisposed neurons to axon overbranching and overgrowth [51]. Moreover, ATAT1 inactivation in sensory neurons determined a deficit in mice ability to respond to mechanical touch and pain [52].
Importantly, absence of ATAT1 causes a massive K40 deacetylation of α-tubulin in various organisms and tissues [18, 22, 23, 32, 42], meaning that its function is not fully compensated for by other enzymes. In specific cell contexts, other lysine acetyltransferases belonging to the GNAT superfamily or to the N-Acetyltransferase (NAT) family have been shown to acetylate α-tubulin on K40 in mammals, suggesting that these enzymes might have minor α-tubulin acetylation activities [53,54,55,56]. In conclusion, ATAT1 is the main K40 α-tubulin acetyltransferase in all species.
Regulation of ATAT1 expression and activity
ATAT1 activity should be finely controlled to achieve the modulation of MT acetylation required in all cellular activities involving cytoskeleton rearrangements; in this context, emerging studies identify upstream and downstream molecular pathways regulating ATAT1 expression and function (Fig. 3). At the transcriptional level, a dramatic down-regulation of ATAT1 mRNA has been observed in retinal epithelial cells devoid of inverted formin 2 (INF2), a formin involved in actin remodelling. The paper identifies the INF2-dependent myocardin-related transcription factor (MRTF)/serum response factor (SRF) transcription complex as controlling ATAT1 transcription by binding the promoter region [57] (Fig. 3a). Furthermore, an epigenetic regulation of ATAT1 expression has been also described. Indeed, by chromatin-immunoprecipitation assays the epigenetic modifier DNA methyltransferase 3 alpha (DNMT3A) was found to bind the promoter region of ATAT1 in bone marrow-derived macrophages and promote mRNA expression. Mechanistically, DNMT3A sustains ATAT1 expression by preventing the association of the histone methyltransferase EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) to the ATAT1 promoter region [58]. ATAT1 mRNA expression is also negatively regulated by the histone acetyltransferase p300 in unperturbed conditions. Following cell stress, p300 is exported from the nucleus to hyperacetylated MTs, relieving its negative regulation on ATAT1 expression [59] (Fig. 3a).
ATAT1 function has also been shown to be controlled by regulated protein degradation. In neurons, the cell cycle regulator p27Kip1 directly binds to ATAT1 and stabilizes it against proteasomal degradation, maintaining MT acetylation and proper MT-dependent intracellular vesicle transport [60]. In line with protein abundance regulating ATAT1 activity, the type III intermediate filament vimentin has been shown to enhance ATAT1 degradation and downregulate α-tubulin acetylation by interacting with ATAT1 [61] (Fig. 3b).
Several studies have shown that ATAT1 activity is regulated by phosphorylation on different residues (Fig. 3c). Upon stress, reactive oxygen species (ROS) are required for MT hyperacetylation through activation of the AMP-activated Protein Kinase (AMPK), which is suggested to phosphorylate ATAT1 [59]. Notably, a further AMPK role in the regulation of ATAT1 expression during stress could not be excluded, as in different cell contexts AMPK phosphorylates and downregulates p300 [62, 63].
Another level of regulation of ATAT1 activity has been identified in the context of the transforming growth factor β (TGF-β) signalling. Here, ATAT1 has been shown to interact with one of the major TGF-β effectors, namely TGF-β-activated kinase 1 (TAK1). TAK1 directly binds and phosphorylates ATAT1 at the S237 position, thus promoting its catalytic activation and MT acetylation to regulate proliferation and metabolism-related pathways [64]. A further paper suggests that S236 phosphorylation on ATAT1 by the TGF-β effector casein kinase 2 (CK2) is required for ATAT1 activation, promoting MT acetylation of fibroblasts grown on soft matrix [65]. Interestingly, correct MT acetylation levels have been found to require p21-activated kinase 1 (PAK1) during platelet formation, a process that requires extensive MT rearrangements [66]. PAK1 has been shown to phosphorylate multiple residues on the ATAT1 C-terminal region and inhibit ATAT1 activity in an in vitro kinase assay [66].
A further level of regulation in ATAT1 activity relies on the intracellular localization of the enzyme. Studies of ATAT1 localization in cells are still scanty due to the suboptimal performance of available antibodies. In human fibroblast cells ATAT1 is predominantly cytosolic but it also localizes at the basal body of the primary cilia in quiescent cells and to centrioles and nucleoli in actively growing cells. Throughout mitosis, ATAT1 is observed at the spindle poles and at the midbody, the bottleneck MT structure necessary for cytokinesis. Furthermore, a faint signal on the chromosomes and daughter nuclei is also observed [67]. These localizations are consistent with the binding of ATAT1 to MTs, while the chromosomal localization of the enzyme needs to be better investigated. Recently, time-lapse microscopy in HeLa cells expressing mVenus-ATAT1 has demonstrated that ATAT1 localization is finely tuned by a delicate balance of nuclear export and import dictated by phosphorylation on its C-terminus, and that nuclear sequestration of ATAT1 acts to inhibit its MT acetylation activity [35] (Fig. 3d). In the C-terminal region, the protein harbours putative NES and NLS signals. Phosphorylation on T322 and S315 by different serine/threonine kinases, such as cyclin-dependent kinase 1 and 2 and protein kinase A results in cytosolic accumulation of ATAT1, whereas nuclear ATAT1 accumulation is favoured by protein phosphatase 2 (PP2A) action. Phosphorylation on T322 and S315 residues prevents NLS interaction with importin-α and promotes ATAT1 binding to specific 14-3-3 adapters, two conditions that enhance ATAT1 accumulation in the cytosol and increase MT acetylation [35]. Based on this work, intracellular ATAT1 localization from regulated nucleus-cytoplasm shuttling may be considered a major mechanism in the regulation of MT acetylation. In conclusion, all these findings suggest that ATAT1 may be controlled both at the transcriptional and post-translational levels to fine-tune its activity in different tissues and under physiological or pathological stimuli.
ATAT1 in cellular functions
Given that acetylated MTs are intimately involved in multiple cell activities, ATAT1 function may have an impact on organismal physiology and in several diseases, including neurodegeneration and cancer, as discussed below.
ATAT1 in regulating cell proliferation and mitosis
Although in vivo studies have not identified defective organismal growth in ATAT1-deficient mice lacking α-tubulin acetylation [23, 42, 49], the role of ATAT1 in cell proliferation is still unclear and may be dependent on cell types and growing conditions. Several reports showed that ATAT1 -/- MEFs grew faster than control cells and exhibited loss of contact inhibition [64, 68], and similar results were obtained in cultured mouse fibroblasts [69].
Notwithstanding, ATAT1 silencing in normal pig kidney epithelial cells has been shown to cause severe mitotic effects, mainly characterised by an impaired MT nucleation at centrosomes linked to a defective centrosome recruitment of polo-like kinase 1 (PLK-1), a major spindle assembly kinase. In addition, ATAT1 silencing was found to result in an impaired interaction between kinetochores and MTs, possibly by producing breaks into the MT bundles interacting with kinetochores [70]. These findings suggest that acetylation of MTs by ATAT1 regulates mitotic spindle plasticity and integrity.
A relevant question is whether ATAT1 effects on cell cycle progression are connected to its influence on MT dynamics. In a recent study, Lopes and coauthors have shown that ATAT1 silencing has no significant effects on the turn-over of mitotic MTs and does not affect MT growth in interphase cells, suggesting that MT dynamics is unperturbed when tubulin acetylation is impeded [71]. These findings, together with the reported effects on mitotic MT integrity [70], could be explained with the proposed action of K40 acetylation and ATAT1 in enhancing MT flexibility and increasing resistance to MT breakage [13, 15]. These functions could be highly relevant in the control of mitotic progression and fidelity.
Primary cilia are post-mitotic cellular organelles detecting extracellular cues [72]. Although α-tubulin acetylation is recognized as an important hallmark of ciliated structures, the role of ATAT1 in ciliogenesis is still controversial. In mice and human cultured cells, ATAT1 knockdown does not abrogate primary cilium formation [23, 42] but alters the normal kinetics of ciliogenesis [22, 73]. Notably, from a molecular point of view ATAT1 catalytic activity has been shown to control non-muscle myosin IIB (Myh10) expression to regulate ciliogenesis kinetics [73].
ATAT1 in cell migration
Cell migration is essential in a broad range of biological processes, including development, immunity, and cancer [74]. Recent evidence suggests that tubulin acetylation and ATAT1 play a crucial role in in vitro and in vivo cell migration [49, 75, 76]. In primary astrocytes, ATAT1 and acetylated MTs have been found to preferentially localize at focal adhesions, thereby regulating cell migration. Indeed, inhibition of ATAT1 expression, leading to decreased K40 tubulin acetylation, reduced the speed of cell migration without affecting migration direction or whole cell movement [75]. In the same study, ATAT1 was found to regulate focal adhesion turnover by promoting the fusion of Rab6-positive vesicles at focal adhesions [75]. Recent evidence shows that, in conditions of substrate rigidity, ATAT1 is recruited to focal adhesions by a talin- and actomyosin-dependent mechanosensing signalling for matrix stiffness-dependent microtubule acetylation [76]. Overall, these studies support the promigratory role of ATAT1-dependent tubulin acetylation in neuronal tissues.
The link between ATAT1 function and migration is corroborated by a further study using human dermal fibroblasts (HDFs). When grown on stiff substrates, HDFs exhibit higher levels of acetylated tubulin and show a greater ability to contract and migrate as compared with cells on soft substrates. Following ATAT1 depletion, HDF contraction and migration were markedly decreased in stiff conditions, concomitantly with a decreased expression of extracellular matrix proteins playing a key role in skin fibrosis [77]. Mechanistically, ATAT1 has been shown to influence the cellular response to matrix stiffness by regulating the phosphorylation of the mechanosensitive protein YAP and controlling its nucleocytoplasmic shuttling [76, 77]. Contrasting results are available on the role of ATAT1 in migrating macrophages [58, 78], whereas live cell imaging of ATAT1-depleted human epithelial cells did not detect any alteration in directed cell migration, cell polarization and cell length in a 1D migration assay [79]. Thus, ATAT1 role in cell migration is still unclear and is likely to depend on cell types and tissue conditions.
ATAT1 in intracellular trafficking
Intracellular trafficking is a tightly regulated MT-dependent process that moves vesicles and substances within the cell [80]. Different studies have shown that MT acetylation promotes the recruitment of both dynein and kinesins to MTs, thereby enhancing bidirectional intracellular trafficking [16, 17, 81]. In neurons, ATAT1-dependent MT acetylation has been linked to the axonal transport of vesicles and organelles [60, 82]. Notably, it has been demonstrated that ATAT1 is transported at the cytosolic side of neuronal vesicles moving along axons, suggesting that this axonal transport of ATAT1-enriched vesicles is the predominant driver of tubulin acetylation in axons [82].
ATAT1 is also implicated in autophagy, a membrane-trafficking pathway that delivers cellular components to the lysosomes for degradation and recycling [83]. ATAT1 silencing has been shown to promote or impair autophagosome maturation in different cellular contexts, so that further studies are needed to better clarify its role in the autophagic process [84, 85].
Several lines of evidence indicate that tubulin acetylation and ATAT1 are also involved in the movement along MTs of cell organelles, such as mitochondria, lysosomes, endosomes, or lipid droplets [81, 86,87,88,89]. Recently, ATAT1 has been found in a multiprotein complex containing GCN5-like 1 (GCN5L1) protein and RAN-binding protein 2 (RANBP2) in hepatocytes, where the complex controls lysosome positioning in the cells [86].
Alcohol consumption has been shown to induce MT acetylation in hepatocytes, which, in turn, leads to the accumulation of large, immobile lipid droplets, storage organelles at the centre of lipid and energy homeostasis. Notably, ATAT1 overexpression in unperturbed conditions was found to enhance dynein binding to large lipid droplets, thereby leading to impaired droplet dynamics [87]. Furthermore, acetaldehyde exposure and ATAT1 overexpression significantly impaired other MT-dependent processes, such as protein secretion and transcytosis, and clathrin-mediated endocytosis in cultured hepatocytes [88].
Recent evidence has shed light on the role of ATAT1 and K40 tubulin acetylation in the global reorganization of organelle intracellular positioning that occurs following centrosome amplification, a condition commonly observed in cancer. In cells with supernumerary centrosomes, several cell organelles are displaced towards the cell periphery and the same is found for the intermediate filament marker vimentin. In these cells, centrosomes, mitochondria, and vimentin displacement has been found to be dependent on ATAT1-mediated MT acetylation that would favour kinesin-1-dependent organelle movement. In contrast, endosomes and Golgi displacement was unaffected by ATAT1 depletion, suggesting that other PTMs or protein adaptors could mediate the relocation of these organelles [81]. Collectively, these data highlight a complex relationship between intracellular trafficking, MTs, and α-tubulin acetyltransferase activity that needs further investigation.
ATAT1 in the response to cellular stress
There is growing evidence that MTs and tubulin PTMs play a critical role both in sensing and responding to cell stress [90]. Indeed, changes in tubulin acetylation status appear as a reversible cell stress response to different stressors; however, the role of ATAT1 in stress response is still understudied. Using ATAT1 -/- MEFs, Yang and collaborators have proved that ATAT1 is a crucial effector of stress-induced α-tubulin hyperacetylation [49]. Interestingly, another study has delineated a role for p300 and AMPK as mediators of ATAT1 activation upon high salt-induced cell stress [59].
A more recent report has identified a role for ATAT1 in the response to genotoxic stress. ATAT1 silencing in HeLa cells reduced DNA damage-induced checkpoint activation in response to the topoisomerase I inhibitor camptothecin. Notably, expression of a wild-type ATAT1 but not of a catalytically inactive protein rescued the checkpoint defect observed in ATAT1 depleted cells, suggesting that ATAT1 impacts on the DNA damage checkpoint via an acetylation-dependent mechanism [91]. Interestingly, silica exposure and matrix stiffening or a combination of both lead to a downregulation of ATAT1-dependent tubulin acetylation with subsequent DNA damage and replication stress in a rat model of silicosis and in a lung cancer cell line [92], confirming a relationship between ATAT1 and DNA damage response.
ATAT1 and MT acetylation also tunes cytoskeletal stiffness, which affects cytoskeletal mechanics and mechano-transduction in specialized cells. In striated muscle, overexpression of ATAT1 increases viscoelastic resistance and dampens contractile kinetics [93]. In astrocytes and endothelial cells, ATAT1 is required for the mechanosensitive regulation of migration [76]. In a rat model of lung silicosis, a fibrotic condition resulting in cell stiffening, a reduced expression of ATAT1 was observed in silicosis nodules or interstitial fibrotic regions along with an increased fibroblast-to-myofibroblast differentiation. ATAT1 down-regulation could be reversed by an anti-fibrotic tetrapeptide, implicating ATAT1-dependent tubulin acetylation as part of an anti-fibrotic mechanism [94].
Emerging roles for ATAT1 in neurological diseases and cancer
In brain tissues, the observed high levels of ATAT1 and of K40 acetyl α-tubulin have been linked to the need of efficient MT-based transport of molecules and organelles in the extended axonal cytoplasm [23, 45, 60, 82, 95, 96]. In line with this, increasing evidence demonstrates the role of ATAT1 function in some neurodegenerative diseases. Studies using β amyloid (Aβ)-secreting cell lines expressing Alzheimer’s disease (AD) mutations, as a cellular model for the disease, demonstrated that the increased MT acetylation and Aβ secretion stimulated by H2O2-induced oxidative stress were dependent on ATAT1 activity [97]. Concordantly, ATAT1 knockdown in the hippocampal region of an AD mouse model produced significant reductions in Aβ plaque accumulation in the cerebrospinal fluid and restored the memory loss, characteristic of this disease model [97]. Overall, these results highlight a link between ATAT1-dependent MT acetylation in response to oxidative stress and amyloid plaque formation in the early stages of AD. Interestingly, inhibition of ATAT1 expression by depletion of the epigenetic modifier METTL3 resulted in alleviated AD symptoms in a disease mouse model by reducing α-tubulin acetylation and enhancing brain migration of monocyte-derived macrophages involved in Aβ plaque clearance [58].
Charcot–Marie–Tooth disease type 2 A (CMT2A) disease is a peripheral neuropathy resulting from mutations in the mitochondrial fusion protein mitofusin-2 (MFN2), a large GTPase implicated in mitochondrial fusion and tethering with the endoplasmic reticulum [98]. A recent paper has shown that the sites of mitochondrial contacts with MTs are regions of high -α-tubulin acetylation which is mediated by the MFN2-dependent recruitment of ATAT1 at these sites, and that this function is important for MFN2-dependent control of mitochondria motility [89]. The findings in the paper suggests that a defective ATAT1-dependent MT acetylation may underly the impaired axonal mitochondrial mobility observed in CMT2A disease [99].
Leucine-rich repeat kinase 2 (LRRK2) mutations are the most common genetic cause of Parkinson disease (PD) [100]. The mutated LRRK2 protein accumulates in filamentous structures that associate with deacetylated MTs, inhibiting axonal transport and causing locomotor deficits in Drosophila LRRK2 mutants. Increasing MT acetylation by deacetylase inhibition prevented the formation of filamentous LRRK2, restored axonal transport in rat cortical neuron cultures and rescued the transport and locomotion deficits in a Drosophila model of the disease. Interestingly, ATAT1 expression also prevented the formation of the mutant LRRK2-dependent filamentous structures [101].
Aberrant levels of tubulin K40 acetylation have been reported in different cancer types [9, 90, 102,103,104,105]. In the last years, many studies have highlighted the involvement of ATAT1 functions in breast tumours [27, 105,106,107], while ATAT1 role in other tumours remains still elusive (Table 2).
In breast cancer, tubulin acetylation and ATAT1 have been found to regulate cell protrusions, adhesion and invasion, key steps of tumour dissemination. In particular, ATAT1 overexpression in a non-metastatic cancer cell line increases K40 tubulin acetylation and enhances the formation of microtentacles, membrane-based protrusions that aid cells in suspension to reattach to the substrate [105], while in a metastatic cancer cell line ATAT1 colocalizes and regulates cortactin acetylation levels, and this colocalization is required for the migratory and invasive capacities of these cells [27]. Silencing of ATAT1 also promotes the accumulation of endosomes containing membrane-type I matrix metalloproteinase (MT1-MMP) at peripheral adhesion sites, suggesting that tubulin hypoacetylation may favour MT1-MMP extracellular delivery for enhancing matrix degradation [27]. In another breast cancer study, ATAT1 catalyses MT acetylation at the membrane-associated clathrin-coated pits through its interaction with the clathrin adaptor AP2 and ATAT1/AP2 interaction is required for directional migration [106]. In cells grown on a stiff matrix, ATAT1 silencing induces ER stress and inhibits cell migration, invasion, proliferation, and spheroid formation, via downregulation of gene expression related to cancer-related pathways [107]. Moreover, analysis of ATAT1 transcripts in breast cancer databases has shown that ATAT1 is upregulated in most cancer tissues when compared to the normal tissues [107]. These findings are consistent with the observation that increased levels of tubulin acetylation correlates with progression and poor prognosis in breast cancer patients [105]. Overall, these studies suggest that ATAT1 may be considered an important molecular marker of invasion and progression in breast cancer.
Interestingly, ATAT1 downregulation also inhibits cell invasion and migration in colon and ameloblastoma cancer cells and induces mitotic catastrophe in lung cancer cells [108,109,110] In contrast, ATAT1 overexpression inhibits cell migratory and invasive ability of lung cancer cells as well as in vivo tumour metastasis [111].
Recent studies have examined the correlation between tubulin acetylation levels and sensitivity to microtubule drugs. While one study showed that ATAT1 silencing did not impact paclitaxel cytotoxicity in colon cancer cells [71], a correlation between high tubulin acetylation levels and paclitaxel resistance was observed in patient-derived lung cancer cells and in paclitaxel-resistant lung cell lines [104]. Interestingly, ATAT1 overexpression was found to mediate paclitaxel resistance by preventing the degradation of Mcl-1, an anti-apoptotic protein involved in paclitaxel resistance [104]. Recently, ATAT1 downregulation has been reported to reduce K40 acetyl tubulin levels and sensitize hepatocellular carcinoma cells to a novel MT-targeting drug [102]. Overall, these studies show that altered α-tubulin acetylation is linked to various human diseases and that ATAT1 may constitute a novel target for drug development and therapeutic intervention.
Recent advances in the development of ATAT1 inhibitors
To the best of our knowledge, only a couple of studies dealing with potential ATAT1 small-molecule inhibitors have been reported so far. In 2021, Yang and collaborators proposed two models of ATAT1 which recapitulate the structural features that the molecules must have for anchoring to the target (indicated as “pharmacophore anchor models”). The authors developed these models according to the structural conformations induced by the ATAT1 natural ligands Ac-CoA and CoA, identified in the analysis of 14 crystal structures of ATAT1 from different protein data banks [112]. These models were statistically constructed using thousands of docked compounds, and allowed to infer the structural moiety preferences with the physico-chemical properties for the binding to the ATAT1 active site. In particular, the proposed pharmacophore anchor models revealed 3 sub-pockets S1 (acetyl site), S2 (adenine site), and S3 (diphosphate site) with 8 anchors where conserved moieties interact with respective sub-pocket residues in each site and helped in guiding ATAT1 inhibitor development. Indeed, once completely validated, the authors applied the model in a virtual screening and predicted 10 potential inhibitors and their binding mechanisms. Despites some of the predicted high-energy binders such as ceftolozane and methotrexate (1, 2 in Fig. 4) are known drugs with a great repurposing potential, none of them has been investigated in in vitro inhibition assays with ATAT1 [112].
In 2020 Song and collaborators reported a series of 2,4-disubstituted thiazole compounds (3–5 in Fig. 4) as inhibitors of MT acetylation in triple-negative breast cancer (TNBC) cells and mouse xenograft models [103]. After a preliminary cell-based screening of a library of about 30,000 small-molecule compounds, the authors identified GM-90,257 (3) as a first hit able to reduce acetyl-α-tubulin levels in breast cancer cells at submicromolar concentrations in a dose-dependent fashion. The optimization of 3 led to the very similar superior homologue GM-90,568 (4) and to its hydrochloride salt GM-90,631 (5) that resulted able to reduce K40 α-tubulin acetylation and disrupt the MT structure in MDA-MB-231 cells at low concentrations (50–100 nM) without affecting α-tubulin expression and histone H3 acetylation. Moreover, the authors observed a decrease of acetyl-α-tubulin levels at pharmacological doses together with a significant reduction of tumor growth in vivo in mouse xenograft TNBC models after intraperitoneal administration of the chemical. Extensive docking simulations performed on enzymes involved in MT acetylation (HDAC6, SIRT2, ATAT1) led the authors to exclude a direct interaction of 3–5 with the active site of these enzymes, while supported their direct binding to the K40 residue of α-tubulin that should prevent ATAT1 from binding to MTs. Despite the proposed mechanism of inhibition as disruptors of the interaction between α-tubulin and ATAT1 should be confirmed by additional more informative experiments, this series of compounds define the only validated chemotype for MT acetylation inhibition available so far.
Open questions and concluding remarks
In the recent years, exciting new links between tubulin acetylation, ATAT1 and a range of cellular functions have been discovered, but several questions remain unanswered. Firstly, it is still to be determined whether ATAT1 can acetylate residues different from K40; indeed, the lack of antibodies capable of detecting other acetylation sites makes it difficult to determine whether K40 of α-tubulin is the only target of ATAT1 on MTs or whether other luminal residues (e.g. K60 or K370) may also be targeted. Furthermore, the functional interaction between ATAT1 and San, the acetylase that modifies K252 on β tubulin, as well as the interplay of ATAT1 with other minor α-tubulin acetylases or with the different tubulin deacetylases is far from being uncovered. Next, the only other protein identified as ATAT1 target so far is cortactin [27], although several mechanistic aspects remain to be explored, including the residue/s that is acetylated and the ATAT1 binding site on the protein. Nevertheless, this study suggest that the number of ATAT1-targeted proteins may increase in the future, opening the possibility for tubulin-independent ATAT1-connected functions. Finally, a kinase-mediated regulation of ATAT1 nuclear export and import has been reported [35]. According to these findings, nuclear localisation of ATAT1 restricts its access to polymerised MTs, thereby finely regulating tubulin K40 acetylation. However, it remains to be clarified whether ATAT1 has also specific function/s once in the nucleus. There, it may take part in multi-protein complex/es, as found in [86], and acetylate as yet unidentified substrates, thereby contributing to key functions in DNA replication and repair processes. Thus, exploring new ATAT1 substrates is a great challenge for the coming years, and will certainly contribute to uncover novel biological pathways regulated by this enzyme.
Interestingly, the K40 residue of α-tubulin is also targeted for tri-methylation (K40me3) by SETD2, a dual-function histone and microtubule methyltransferase [113]. K40me3 is associated with polymerized MTs in cells and promotes MT stabilization in vitro [113, 114]. Furthermore, it has been observed that α-tubulin K40me3 is increased in the absence of K40 acetylation, and that this increase rescues the defects in radial migration and morphological transition of cortical neurons caused by ATAT1 depletion [114]. These results suggest that the two modifications may have overlapping effects, but it is still to be determined whether the two enzymes compete to access the K40 residue and their functional interactions in specific cellular events.
Finally, several reports have indicated acetylation independent ATAT1 activities in different organisms, mostly in neuronal tissues suggesting that ATAT1 might exert also structural functions in neuronal cell harbouring extended axonal MTs [30, 32, 42]. Both functions may contribute to maintain a functional MT network both by local enzymatic activity and by promoting ATAT1 accumulation on long-lived MTs. Structural/signalling ATAT1 activities appear to be relevant during neuron development and are likely to be important in neuronal aging and neurodegenerative diseases [30, 50]. Nevertheless, the importance of non-enzymatic activities in other ATAT1-related functions, including cell migration and non-axonal intracellular transport, as well as in non-neuronal diseases such as cancer, are still to be clarified.
Despite recent evidence which points to ATAT1 and K40 tubulin acetylation as significant players in several types of cancer, in particular breast cancer [90, 102,103,104,105,106], little is known about the underlying mechanisms and the relevance of ATAT1 acetyltransferase activity in the cancer process. Further investigations are needed to better clarify the pathological role of ATAT1 in cell transformation and cancer progression, in which the identification of novel targets and pathways regulated by ATAT1 might represent an important advance toward a more personalized treatment of human tumours.
Data availability
Not applicable.
References
Chaaban S, Brouhard GJ (2017) A microtubule bestiary: structural diversity in tubulin polymers. Mol Biol Cell 28:2924–2931. https://doi.org/10.1091/MBC.E16-05-0271
Loreng TD, Smith EF (2017) The Central Apparatus of Cilia and Eukaryotic Flagella. Cold Spring Harb Perspect Biol 9. https://doi.org/10.1101/CSHPERSPECT.A028118
Roll-Mecak A (2020) The Tubulin Code in Microtubule Dynamics and Information Encoding. Dev Cell 54:7–20. https://doi.org/10.1016/J.DEVCEL.2020.06.008
Janke C, Magiera MM (2020) The tubulin code and its role in controlling microtubule properties and functions. Nat Rev Mol Cell Biol 21:307–326. https://doi.org/10.1038/S41580-020-0214-3
Choudhary C, Kumar C, Gnad F et al (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Sci (1979) 325:834–840. https://doi.org/10.1126/SCIENCE.1175371
Chu CW, Hou F, Zhang J et al (2011) A novel acetylation of β-tubulin by San modulates microtubule polymerization via down-regulating tubulin incorporation. Mol Biol Cell 22:448–456. https://doi.org/10.1091/MBC.E10-03-0203/ASSET/IMAGES/LARGE/448FIG7.JPEG
Liu N, Xiong Y, Ren Y et al (2015) Proteomic profiling and functional characterization of multiple post-translational modifications of Tubulin. J Proteome Res 14:3292–3304. https://doi.org/10.1021/ACS.JPROTEOME.5B00308/SUPPL_FILE/PR5B00308_SI_004.PDF
Liu N, Xiong Y, Li S et al (2015) New HDAC6-mediated deacetylation sites of tubulin in the mouse brain identified by quantitative mass spectrometry. Sci Rep 5. https://doi.org/10.1038/SREP16869
Nekooki-Machida Y, Hagiwara H (2020) Role of tubulin acetylation in cellular functions and diseases. Med Mol Morphol 53:191–197. https://doi.org/10.1007/S00795-020-00260-8
Weinert BT, Wagner SA, Horn H et al (2011) Proteome-wide mapping of the Drosophila acetylome demonstrates a high degree of conservation of lysine acetylation. Sci Signal 4. https://doi.org/10.1126/SCISIGNAL.2001902
Lundby A, Lage K, Weinert BT et al (2012) Proteomic Analysis of Lysine Acetylation Sites in Rat tissues reveals Organ specificity and subcellular patterns. Cell Rep 2:419. https://doi.org/10.1016/J.CELREP.2012.07.006
Saunders HAJ, Johnson-Schlitz DM, Jenkins BV et al (2022) Acetylated α-tubulin K394 regulates microtubule stability to shape the growth of axon terminals. Curr Biol 32:614–630e5. https://doi.org/10.1016/J.CUB.2021.12.012
Xu Z, Schaedel L, Portran D et al (2017) Microtubules acquire resistance from mechanical breakage through intralumenal acetylation. Science (1979) 356:328–332. https://doi.org/10.1126/SCIENCE.AAI8764/SUPPL_FILE/MOVIES_S5-S10.ZIP
Piperno G, LeDizet M, Chang XJ (1987) Microtubules containing acetylated alpha-tubulin in mammalian cells in culture. J Cell Biol 104:289–302. https://doi.org/10.1083/JCB.104.2.289
Portran D, Schaedel L, Xu Z et al (2017) Tubulin acetylation protects long-lived microtubules against mechanical aging. Nat Cell Biol 19:391. https://doi.org/10.1038/NCB3481
Reed NA, Cai D, Blasius TL et al (2006) Microtubule acetylation promotes kinesin-1 binding and transport. Curr Biol 16:2166–2172. https://doi.org/10.1016/J.CUB.2006.09.014
Dompierre JP, Godin JD, Charrin BC et al (2007) Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington’s disease by increasing tubulin acetylation. J Neurosci 27:3571–3583. https://doi.org/10.1523/JNEUROSCI.0037-07.2007
Yan C, Wang F, Peng Y et al (2018) Microtubule Acetylation is required for mechanosensation in Drosophila. Cell Rep 25:1051–1065e6. https://doi.org/10.1016/J.CELREP.2018.09.075
Prokop A (2022) Microtubule regulation: transcending the tenet of K40 acetylation. Curr Biol 32:R126–R128. https://doi.org/10.1016/J.CUB.2021.12.018
Jenkins BV, Saunders HAJ, Record HL et al (2017) Effects of mutating α-tubulin lysine 40 on sensory dendrite development. J Cell Sci 130:4120–4131. http:///AM/EFFECTS-OF-MUTATING-TUBULIN-LYSINE-40-ON-SENSORY https://doi.org/10.1242/JCS.210203/265552.
Gaertig J, Cruz MA, Bowen J et al (1995) Acetylation of lysine 40 in alpha-tubulin is not essential in Tetrahymena Thermophila. J Cell Biol 129:1301–1310. https://doi.org/10.1083/JCB.129.5.1301
Shida T, Cueva JG, Xu Z et al (2010) The major α-tubulin K40 acetyltransferase αTAT1 promotes rapid ciliogenesis and efficient mechanosensation. Proc Natl Acad Sci U S A 107:21517–21522. https://doi.org/10.1073/PNAS.1013728107/SUPPL_FILE/SD01.XLS
Kim G-W, Li L, Ghorbani M et al (2013) Mice lacking α-tubulin acetyltransferase 1 are viable but display α-tubulin acetylation deficiency and dentate gyrus distortion. J Biol Chem 288:20334–20350. https://doi.org/10.1074/jbc.M113.464792
Janke C, Montagnac G (2017) Causes and consequences of Microtubule Acetylation. Curr Biol 27:R1287–R1292. https://doi.org/10.1016/J.CUB.2017.10.044
Bär J, Popp Y, Bucher M, Mikhaylova M (2022) Direct and indirect effects of tubulin post-translational modifications on microtubule stability: insights and regulations. Biochim Biophys Acta Mol Cell Res 1869. https://doi.org/10.1016/J.BBAMCR.2022.119241
Magiera MM, Singh P, Gadadhar S, Janke C (2018) Tubulin posttranslational modifications and emerging links to Human Disease. Cell 173:1323–1327. https://doi.org/10.1016/J.CELL.2018.05.018
Castro-Castro A, Janke C, Montagnac G et al (2012) ATAT1/MEC-17 acetyltransferase and HDAC6 deacetylase control a balance of acetylation of alpha-tubulin and cortactin and regulate MT1-MMP trafficking and breast tumor cell invasion. Eur J Cell Biol 91:950–960. https://doi.org/10.1016/J.EJCB.2012.07.001
Kalebic N, Martinez C, Perlas E et al (2023) Tubulin Acetyltransferase αTAT1 Destabilizes Microtubules Independently of Its Acetylation Activity. https://doi.org/101128/MCB01044-12 33:1114–1123
Teoh JS, Vasudevan A, Wang W et al (2022) Synaptic branch stability is mediated by non-enzymatic functions of MEC-17/αTAT1 and ATAT-2. Sci Rep 12. https://doi.org/10.1038/S41598-022-18333-2
Coombes CE, Saunders HAJ, Mannava AG et al (2020) Non-enzymatic activity of the α-Tubulin acetyltransferase αTAT limits synaptic Bouton Growth in neurons. Curr Biol 30:610–623e5. https://doi.org/10.1016/J.CUB.2019.12.022
Topalidou I, Keller C, Kalebic N et al (2012) Genetically separable functions of the MEC-17 tubulin acetyltransferase affect Microtubule Organization. Curr Biol 22:1057–1065. https://doi.org/10.1016/J.CUB.2012.03.066
Akella JS, Wloga D, Kim J et al (2010) MEC-17 is an α-tubulin acetyltransferase. Nature 2010 467:7312 467:218–222. https://doi.org/10.1038/nature09324
Vetting MW, Luiz LP, Yu M et al (2005) Structure and functions of the GNAT superfamily of acetyltransferases. Arch Biochem Biophys 433:212–226. https://doi.org/10.1016/J.ABB.2004.09.003
Friedmann DR, Aguilar A, Fan J et al (2012) Structure of the α-tubulin acetyltransferase, αTAT1, and implications for tubulin-specific acetylation. Proc Natl Acad Sci U S A 109:19655–19660. https://doi.org/10.1073/PNAS.1209357109/SUPPL_FILE/PNAS.201209357SI.PDF
Roy AD, Gross EG, Pillai GS et al (2022) Non-catalytic allostery in α-TAT1 by a phospho-switch drives dynamic microtubule acetylation. J Cell Biol 221. https://doi.org/10.1083/JCB.202202100
Davenport AM, Collins LN, Chiu H et al (2014) Structural and functional characterization of the α-tubulin acetyltransferase MEC-17. J Mol Biol 426:2605. https://doi.org/10.1016/J.JMB.2014.05.009
Taschner M, Vetter M, Lorentzen E (2012) Atomic resolution structure of human α-tubulin acetyltransferase bound to acetyl-CoA. Proc Natl Acad Sci U S A 109:19649–19654. https://doi.org/10.1073/PNAS.1209343109
Kormendi V, Szyk A, Piszczek G, Roll-Mecak A (2012) Crystal Structures of Tubulin Acetyltransferase Reveal a Conserved Catalytic Core and the plasticity of the essential N terminus. J Biol Chem 287:41569. https://doi.org/10.1074/JBC.C112.421222
Yuzawa S, Kamakura S, Hayase J, Sumimoto H (2015) Structural basis of cofactor-mediated stabilization and substrate recognition of the α-tubulin acetyltransferase αTAT1. Biochem J 467:103–113. https://doi.org/10.1042/BJ20141193
Coombes C, Yamamoto A, McClellan M et al (2016) Mechanism of microtubule lumen entry for the α-tubulin acetyltransferase enzyme αTAT1. Proc Natl Acad Sci U S A 113:E7176–E7184. https://doi.org/10.1073/PNAS.1605397113/SUPPL_FILE/PNAS.1605397113.SM03.MOV
Howes SC, Alushin GM, Shida T et al (2014) Effects of tubulin acetylation and tubulin acetyltransferase binding on microtubule structure. Mol Biol Cell 25:257–266. https://doi.org/10.1091/MBC.E13-07-0387
Kalebic N, Sorrentino S, Perlas E et al (2013) αTAT1 is the major α-tubulin acetyltransferase in mice. Nature Communications 2013 4:1 4:1–10. https://doi.org/10.1038/ncomms2962
Zhang Y, Ma C, Delohery T et al (2002) Identification of genes expressed in C. Elegans touch receptor neurons. Nature 418:331–335. https://doi.org/10.1038/NATURE00891
Cueva JG, Hsin J, Huang KC, Goodman MB (2012) Posttranslational acetylation of α-Tubulin constrains protofilament number in native microtubules. Curr Biol 22:1066–1074. https://doi.org/10.1016/J.CUB.2012.05.012
Neumann B, Hilliard MA (2014) Loss of MEC-17 leads to microtubule instability and axonal degeneration. Cell Rep 6:93–103. https://doi.org/10.1016/J.CELREP.2013.12.004
Dobbelaere J, Schmidt Cernohorska M, Huranova M et al (2020) Cep97 is required for Centriole Structural Integrity and Cilia formation in Drosophila. Curr Biol 30:3045–3056e7. https://doi.org/10.1016/J.CUB.2020.05.078
Niu X, Mao CX, Wang S et al (2023) α-Tubulin acetylation at lysine 40 regulates dendritic arborization and larval locomotion by promoting microtubule stability in Drosophila. PLoS ONE 18. https://doi.org/10.1371/JOURNAL.PONE.0280573
Yanai R, Yamashita Y, Umezu K et al (2021) Expression and localization of alpha-tubulin N-acetyltransferase 1 in the reproductive system of male mice. J Reprod Dev 67:59–66. https://doi.org/10.1262/JRD.2020-110
Li L, Jayabal S, Ghorbani M et al (2019) ATAT1 regulates forebrain development and stress-induced tubulin hyperacetylation. Cell Mol Life Sci 76:3621–3640. https://doi.org/10.1007/S00018-019-03088-3
Li L, Wei D, Wang Q et al (2012) MEC-17 deficiency leads to reduced α-tubulin acetylation and impaired migration of cortical neurons. J Neurosci 32:12673–12683. https://doi.org/10.1523/JNEUROSCI.0016-12.2012
Wei D, Gao N, Li L et al (2018) α-Tubulin Acetylation restricts Axon Overbranching by dampening Microtubule Plus-End dynamics in neurons. Cereb Cortex 28:3332–3346. https://doi.org/10.1093/CERCOR/BHX225
Morley SJ, Qi Y, Iovino L et al (2016) Acetylated tubulin is essential for touch sensation in mice. Elife 5:25. https://doi.org/10.7554/ELIFE.20813
Creppe C, Malinouskaya L, Volvert ML et al (2009) Elongator Controls the Migration and Differentiation of Cortical Neurons through Acetylation of α-Tubulin. Cell 136:551–564. https://doi.org/10.1016/J.CELL.2008.11.043
Ohkawa N, Sugisaki S, Tokunaga E et al (2008) N-acetyltransferase ARD1-NAT1 regulates neuronal dendritic development. Genes Cells 13:1171–1183. https://doi.org/10.1111/J.1365-2443.2008.01235.X
Lin G, Lin H, Zhuo R et al (2022) GCN5/KAT2A contributes to axon growth and neurogenesis. Neurosci Lett 784:136742. https://doi.org/10.1016/J.NEULET.2022.136742
Ouyang C, Mu J, Lu Q et al (2020) Autophagic degradation of KAT2A/GCN5 promotes directional migration of vascular smooth muscle cells by reducing TUBA/α-tubulin acetylation. Autophagy 16:1753–1770. https://doi.org/10.1080/15548627.2019.1707488
Fernández-Barrera J, Bernabé-Rubio M, Casares-Arias J et al (2018) The actin-MRTF-SRF transcriptional circuit controls tubulin acetylation via α-TAT1 gene expression. J Cell Biol 217:929–944. https://doi.org/10.1083/JCB.201702157
Yin H, Ju Z, Zheng M et al (2023) Loss of the m6A methyltransferase METTL3 in monocyte-derived macrophages ameliorates Alzheimer’s disease pathology in mice. PLoS Biol 21:e3002017. https://doi.org/10.1371/JOURNAL.PBIO.3002017
Mackeh R, Lorin S, Ratier A et al (2014) Reactive oxygen species, AMP-activated protein kinase, and the transcription cofactor p300 regulate α-Tubulin Acetyltransferase-1 (αTAT-1/MEC-17)-dependent Microtubule Hyperacetylation during cell stress. J Biol Chem 289:11816–11828. https://doi.org/10.1074/JBC.M113.507400
Morelli G, Even A, Gladwyn-Ng I et al (2018) p27Kip1 Modulates Axonal Transport by regulating α-Tubulin acetyltransferase 1 Stability. Cell Rep 23:2429–2442. https://doi.org/10.1016/J.CELREP.2018.04.083
Liu P, Zhang S, Ma J et al (2022) Vimentin inhibits α-tubulin acetylation via enhancing α-TAT1 degradation to suppress the replication of human parainfluenza virus type 3. PLoS Pathog 18:e1010856. https://doi.org/10.1371/JOURNAL.PPAT.1010856
Zhang Y, Qiu J, Wang X et al (2011) AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300. Arterioscler Thromb Vasc Biol 31:2897–2908. https://doi.org/10.1161/ATVBAHA.111.237453
Yang W, Hong YH, Shen XQ et al (2001) Regulation of transcription by AMP-activated protein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors. J Biol Chem 276:38341–38344. https://doi.org/10.1074/JBC.C100316200
Shah N, Kumar S, Zaman N et al (2018) TAK1 activation of alpha-TAT1 and microtubule hyperacetylation control AKT signaling and cell growth. Nat Commun 9. https://doi.org/10.1038/S41467-018-04121-Y
You E, Jeong J, Lee J et al (2022) Casein kinase 2 promotes the TGF-β-induced activation of α-tubulin acetyltransferase 1 in fibroblasts cultured on a soft matrix. BMB Rep 55:192. https://doi.org/10.5483/BMBREP.2022.55.4.021
Van Dijk J, Bompard G, Rabeharivelo G et al (2020) PAK1 regulates MEC-17 acetyltransferase activity and microtubule acetylation during Proplatelet Extension. Int J Mol Sci 21:1–17. https://doi.org/10.3390/IJMS21207531
Nekooki-Machida Y, Nakakura T, Nishijima Y et al (2018) Dynamic localization of α-tubulin acetyltransferase ATAT1 through the cell cycle in human fibroblastic KD cells. Med Mol Morphol 51:217–226. https://doi.org/10.1007/S00795-018-0195-X/FIGURES/5
Aguilar A, Becker L, Tedeschi T et al (2014) α-tubulin K40 acetylation is required for contact inhibition of proliferation and cell-substrate adhesion. Mol Biol Cell 25:1854–1866. https://doi.org/10.1091/MBC.E13-10-0609/ASSET/IMAGES/LARGE/1854FIG4.JPEG
Rahimi AM, Cai M, Kılıҫ I et al (2021) Expression of α-Tubulin acetyltransferase 1 and Tubulin Acetylation as Selective forces in Cell Competition. Cells 10:1–20. https://doi.org/10.3390/CELLS10020390
Rasamizafy SF, Delsert C, Rabeharivelo G et al (2021) Mitotic acetylation of Microtubules promotes centrosomal PLK1 recruitment and is required to maintain bipolar spindle homeostasis. https://doi.org/10.3390/CELLS10081859. Cells 10:
Lopes D, Seabra AL, Orr B, Maiato H (2023) α-Tubulin detyrosination links the suppression of MCAK activity with taxol cytotoxicity. J Cell Biol 222. https://doi.org/10.1083/JCB.202205092/213730
Nishimura Y, Kasahara K, Shiromizu T et al (2018) Primary Cilia as Signaling hubs in Health and Disease. Adv Sci (Weinh) 6. https://doi.org/10.1002/ADVS.201801138
Rao Y, Hao R, Wang B, Yao TP (2014) A Mec17-Myosin II Effector Axis coordinates microtubule acetylation and Actin Dynamics to Control Primary Cilium Biogenesis. PLoS ONE 9. https://doi.org/10.1371/JOURNAL.PONE.0114087
Shellard A, Mayor R (2020) All roads lead to Directional Cell Migration. Trends Cell Biol 30:852–868. https://doi.org/10.1016/J.TCB.2020.08.002
Bance B, Seetharaman S, Leduc C et al (2019) Microtubule acetylation but not detyrosination promotes focal adhesion dynamics and astrocyte migration. J Cell Sci 132. https://doi.org/10.1242/JCS.225805
Seetharaman S, Vianay B, Roca V et al (2022) Microtubules tune mechanosensitive cell responses. Nat Mater 21:366–377. https://doi.org/10.1038/S41563-021-01108-X
Wen D, Gao Y, Liu Y et al (2023) Matrix stiffness-induced α-tubulin acetylation is required for skin fibrosis formation through activation of yes-associated protein. MedComm (Beijing) 4. https://doi.org/10.1002/MCO2.319
Bhuwania R, Castro-Castro A, Linder S (2014) Microtubule acetylation regulates dynamics of KIF1C-powered vesicles and contact of microtubule plus ends with podosomes. Eur J Cell Biol 93:424–437. https://doi.org/10.1016/J.EJCB.2014.07.006
Lavrsen K, Rajendraprasad G, Leda M et al (2023) Microtubule detyrosination drives symmetry breaking to polarize cells for directed cell migration. Proc Natl Acad Sci U S A 120. https://doi.org/10.1073/PNAS.2300322120
Barlan K, Gelfand VI (2010) Intracellular transport: ER and mitochondria meet and greet along designated tracks. Curr Biol 20. https://doi.org/10.1016/J.CUB.2010.08.058
Monteiro P, Yeon B, Wallis SS, Godinho SA (2023) Centrosome amplification fine tunes tubulin acetylation to differentially control intracellular organization. EMBO J 42. https://doi.org/10.15252/EMBJ.2022112812
Even A, Morelli G, Broix L et al (2019) ATAT1-enriched vesicles promote microtubule acetylation via axonal transport. Sci Adv 5. https://doi.org/10.1126/sciadv.aax2705
Yang Y, Klionsky DJ (2020) Autophagy and disease: unanswered questions. Cell Death Differ 27:858–871. https://doi.org/10.1038/S41418-019-0480-9
Ragazzoni Y, Desideri M, Gabellini C et al (2013) The thiazole derivative CPTH6 impairs autophagy. Cell Death Dis. https://doi.org/10.1038/CDDIS.2013.53. 4:
Nowosad A, Creff J, Jeannot P et al (2021) p27 controls autophagic vesicle trafficking in glucose-deprived cells via the regulation of ATAT1-mediated microtubule acetylation. Cell Death Dis 12. https://doi.org/10.1038/S41419-021-03759-9
Wu K, Wang L, Chen Y et al (2018) GCN5L1 interacts with αTAT1 and RanBP2 to regulate hepatic α-tubulin acetylation and lysosome trafficking. J Cell Sci 131. https://doi.org/10.1242/JCS.221036
Groebner JL, Girón-Bravo MT, Rothberg ML et al (2019) Alcohol-induced microtubule acetylation leads to the accumulation of large, immobile lipid droplets. Am J Physiol Gastrointest Liver Physiol 317:G373–G386. https://doi.org/10.1152/AJPGI.00026.2019
Adhikari R, Mitra R, Bennett RG et al (2023) Alcohol-induced tubulin post-translational modifications directly alter hepatic protein trafficking. Hepatol Commun 7. https://doi.org/10.1097/HC9.0000000000000103
Kumar A, Larrea D, Pero ME et al (2023) MFN2-dependent recruitment of ATAT1 coordinates mitochondria motility with alpha-tubulin acetylation and is disrupted in CMT2A. https://doi.org/10.1101/2023.03.15.532838. bioRxiv
Parker AL, Kavallaris M, McCarroll JA (2014) Microtubules and their role in cellular stress in cancer. Front Oncol 4. https://doi.org/10.3389/FONC.2014.00153
Ryu NM, Kim JM (2020) The role of the α-tubulin acetyltransferase αTAT1 in the DNA damage response. J Cell Sci 133. https://doi.org/10.1242/JCS.246702
Li G, Chen S, Zhang Y et al (2021) Matrix stiffness regulates α-TAT1-mediated acetylation of α-tubulin and promotes silica-induced epithelial-mesenchymal transition via DNA damage. J Cell Sci 134. https://doi.org/10.1242/JCS.243394
Coleman AK, Joca HC, Shi G et al (2021) Tubulin acetylation increases cytoskeletal stiffness to regulate mechanotransduction in striated muscle. J Gen Physiol 153. https://doi.org/10.1085/JGP.202012743
Xiaojun W, Yan L, Hong X et al (2016) Acetylated α-Tubulin regulated by N-Acetyl-seryl-aspartyl-Lysyl-Proline(Ac-SDKP) exerts the anti-fibrotic effect in Rat Lung Fibrosis Induced by Silica. Sci Rep 6. https://doi.org/10.1038/SREP32257
Baloh RH, Schmidt RE, Pestronk A, Milbrandt J (2007) Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-tooth disease from mitofusin 2 mutations. J Neurosci 27:422–430. https://doi.org/10.1523/JNEUROSCI.4798-06.2007
Fazal R, Boeynaems S, Swijsen A et al (2021) HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations. EMBO J 40. https://doi.org/10.15252/EMBJ.2020106177
Jeong J, Kim OH, Shim J et al (2023) Microtubule acetylation induced by oxidative stress regulates subcellular distribution of lysosomal vesicles for amyloid-beta secretion. J Cell Physiol. https://doi.org/10.1002/JCP.31131
Morena J, Gupta A, Hoyle JC (2019) Charcot-Marie-Tooth: from molecules to Therapy. Int J Mol Sci 20. https://doi.org/10.3390/IJMS20143419
Schiavon CR, Shadel GS, Manor U (2021) Impaired mitochondrial mobility in Charcot-Marie-tooth disease. Front Cell Dev Biol. https://doi.org/10.3389/FCELL.2021.624823. 9:
Zimprich A, Biskup S, Leitner P et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601–607. https://doi.org/10.1016/j.neuron.2004.11.005
Godena VK, Brookes-Hocking N, Moller A et al (2014) Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations. Nat Commun 5. https://doi.org/10.1038/NCOMMS6245
Zhong Y, Wang C, Wang Y et al (2023) Suppression of alpha-tubulin acetylation potentiates therapeutic efficacy of Eribulin in liver cancer. Am J Cancer Res 13:5698–5718
Kwon A, Lee G, Bin, Park T et al (2020) Potent small-molecule inhibitors targeting acetylated microtubules as Anticancer agents against Triple-negative breast Cancer. https://doi.org/10.3390/BIOMEDICINES8090338. Biomedicines 8:
Wattanathamsan O, Thararattanobon R, Rodsiri R et al (2021) Tubulin acetylation enhances lung cancer resistance to paclitaxel-induced cell death through Mcl-1 stabilization. Cell Death Discov 7. https://doi.org/10.1038/S41420-021-00453-9
Boggs AE, Vitolo MI, Whipple RA et al (2015) α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration. Cancer Res 75:203–215. https://doi.org/10.1158/0008-5472.CAN-13-3563
Montagnac G, Meas-Yedid V, Irondelle M et al (2013) αTAT1 catalyses microtubule acetylation at clathrin-coated pits. Nature 502:567–570. https://doi.org/10.1038/NATURE12571
Ko P, Choi JH, Song S et al (2021) Microtubule acetylation controls mda-mb-231 breast cancer cell invasion through the modulation of endoplasmic reticulum stress. Int J Mol Sci 22. https://doi.org/10.3390/ijms22116018
Yoshimoto S, Morita H, Okamura K et al (2022) αTAT1-induced tubulin acetylation promotes ameloblastoma migration and invasion. Lab Invest 102:80–89. https://doi.org/10.1038/S41374-021-00671-W
Oh S, You E, Ko P et al (2017) Genetic disruption of tubulin acetyltransferase, αTAT1, inhibits proliferation and invasion of colon cancer cells through decreases in Wnt1/β-catenin signaling. Biochem Biophys Res Commun 482:8–14. https://doi.org/10.1016/J.BBRC.2016.11.039
Chien JY, Tsen SD, Chien CC et al (2016) αTAT1 downregulation induces mitotic catastrophe in HeLa and A549 cells. Cell Death Discov 2. https://doi.org/10.1038/CDDISCOVERY.2016.6
Lee CC, Cheng YC, Chang CY et al (2018) Alpha-tubulin acetyltransferase/MEC-17 regulates cancer cell migration and invasion through epithelial-mesenchymal transition suppression and cell polarity disruption. Sci Rep 8. https://doi.org/10.1038/S41598-018-35392-6
Hsu NY, Pathak N, Chen YT et al (2021) Pharmacophore Anchor models of ATAT1 to discover potential inhibitors and lead optimization. Comput Biol Chem 93. https://doi.org/10.1016/J.COMPBIOLCHEM.2021.107513
Park IY, Powell RT, Tripathi DN et al (2016) Dual chromatin and cytoskeletal remodeling by SETD2. Cell 166:950–962. https://doi.org/10.1016/J.CELL.2016.07.005
Xie X, Wang S, Li M et al (2021) α-TubK40me3 is required for neuronal polarization and migration by promoting microtubule formation. Nat Commun 12. https://doi.org/10.1038/S41467-021-24376-2
Acknowledgements
Not applicable.
Funding
Research in the laboratory is supported by AIRC IG 2020 via a personal grant to D.T. (#24942), and is partially supported by POR FESR Lazio 2014–2020, Regione Lazio Progetti di Gruppi di Ricerca 2020, grant number A0375-2020-36597 to D.R. and F.D. and by CNR project FOE-2021 DBA.AD005.225 to D.T. We acknowledge co-funding from Next Generation EU, in the context of the National Recovery and Resilience Plan, Investment PE8 – Project Age-It: “Ageing Well in an Ageing Society” [DM 1557 11.10.2022] to D.T. The views and opinions expressed are only those of the authors and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the European Commission can be held responsible for them.
Open access funding provided by Consiglio Nazionale Delle Ricerche (CNR) within the CRUI-CARE Agreement.
Author information
Authors and Affiliations
Contributions
D.T. conceived the idea for the project and acquired the main financial support leading to this publication., D.T. and F.D. contributed to the conceptual framework and structure of the review and to the final editing of the manuscript. D.T., F.D., D.R. contribute to writing and provided comments on the manuscript. A.I. and F.R.P. wrote the first draft, conceived and drew the figures, and prepared the tables. All authors have read and approved the manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
No ethical approval is required.
Consent for publication
This manuscript does not contain any individual person’s data in any form.
Competing Interests
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Iuzzolino, A., Pellegrini, F.R., Rotili, D. et al. The α-tubulin acetyltransferase ATAT1: structure, cellular functions, and its emerging role in human diseases. Cell. Mol. Life Sci. 81, 193 (2024). https://doi.org/10.1007/s00018-024-05227-x
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00018-024-05227-x